These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26920084)

  • 1. Comment on Stotler BA, Schwartz J. How we use WinRho in patients with idiopathic thrombocytopenic purpura. Transfusion 2015:55:2547-50.: This article is a comment on Stotler and Schwartz [2015] DOI: 10.1111/trf.13185.
    Simon TL
    Transfusion; 2016 Apr; 56(4):999. PubMed ID: 26920084
    [No Abstract]   [Full Text] [Related]  

  • 2. How we use WinRho in patients with idiopathic thrombocytopenic purpura.
    Stotler BA; Schwartz J
    Transfusion; 2015 Nov; 55(11):2547-50. PubMed ID: 26094894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of infectious mononucleosis-associated immune thrombocytopenia with WinRho anti-D immunoglobulin complicated by severe hemolysis.
    Olofinboba KA; Greenberg BR
    Am J Hematol; 2000 Oct; 65(2):178. PubMed ID: 10996841
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Golla S; Horkan C; Dogaru G; Teske TE; Christopher K
    Acta Haematol; 2008; 120(2):100-3. PubMed ID: 18957844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC
    Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intravenous immunoglobulin and high dose anti-D immunoglobulin as initial therapy for childhood immune thrombocytopenic purpura.
    Ozsoylu S
    Br J Haematol; 2011 Mar; 152(6):783-4. PubMed ID: 21275947
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequelae of treatment of ITP with anti-D (Rho) immunoglobulin.
    Imbach P; Kühne T
    Lancet; 2000 Aug; 356(9228):447-8. PubMed ID: 10981885
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous rho (D) immune globulin.
    Sandler SG
    Transfus Med Rev; 2001 Jan; 15(1):67-76. PubMed ID: 11149979
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebral venous thrombosis after immune thrombocytopenic purpura and anti-D immune globulin therapy.
    Kayyali HR; Abdelmoity AT; Morriss MC; Graf WD
    J Child Neurol; 2008 Mar; 23(3):325-30. PubMed ID: 18184936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute idiopathic thrombocytopenic purpura of childhood-diagnosis and therapy.
    Panepinto JA; Brousseau DC
    Pediatr Emerg Care; 2005 Oct; 21(10):691-5; quiz 696-8. PubMed ID: 16215478
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe acute renal failure due to hemoglobinuria after use of WinRho for the treatment of idiopathic thrombocytopenic purpura.
    Roberti I; Bagtas JF; Reisman L; Murphy S
    Clin Pediatr (Phila); 2001 Jan; 40(1):61-2. PubMed ID: 11210091
    [No Abstract]   [Full Text] [Related]  

  • 12. New therapies for immune thrombocytopenic purpura.
    Andemariam B; Bussel J
    Curr Opin Hematol; 2007 Sep; 14(5):427-31. PubMed ID: 17934347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production.
    Semple JW; Allen D; Rutherford M; Woloski M; David M; Wakefield C; Butchart S; Freedman J; Blanchette V;
    Am J Hematol; 2002 Mar; 69(3):225-7. PubMed ID: 11891813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
    Yetgin S; Aytaç S; Olcay L; Tunç B; Ozbek N; Aydinok Y
    Turk J Pediatr; 2010; 52(2):126-31. PubMed ID: 20560246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
    Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R
    Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the treatment of idiopathic thrombocytopenic purpura: the anti-D clinical experience.
    Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):1-4. PubMed ID: 9523742
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety profile of WinRho anti-D.
    Hong F; Ruiz R; Price H; Griffiths A; Malinoski F; Woloski M
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):9-13. PubMed ID: 9523744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.